Ulta Beauty (ULTA) stock declined by 2.57% during a recent trading session, contrasting with a general market uptick. The company's shares have underperformed the Retail-Wholesale sector and the S&P 500 over the past month. Investors are anticipating Ulta Beauty's upcoming earnings report on June 2, 2026, with Zacks analysts projecting EPS growth of 2.99% and revenue growth of 8.16% year-over-year.

Aytu BioPharma, Inc. (AYTU) reported a Q3 loss of $0.53 per share, missing the Zacks Consensus Estimate of a $0.31 loss. Despite the earnings miss, the company surpassed revenue estimates with $12.41 million for the quarter, though this was lower than the previous year's $18.45 million. AYTU currently holds a Zacks Rank #3 (Hold), indicating that its shares are expected to perform in line with the market in the near future.

State Street Corporation and its global affiliates have updated their substantial holding in Westpac Banking Corporation (AU:WBC). The disclosure confirms that State Street entities maintain significant, actively managed voting and disposal interests in Westpac shares through various investment management, trustee roles, and securities lending arrangements. This indicates continued offshore institutional engagement with Westpac's stock.

3M Company (MMM) recently held its 2026 annual shareholders meeting where shareholders elected all ten nominees to the Board of Directors for a one-year term. They also ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 and approved the compensation of named executive officers. These decisions reflect shareholder confidence in the company's leadership and strategic direction.

Sempra director Anya Weaving reported an acquisition of 1,499 shares of common stock on May 12, 2026, as a compensation-related award. The shares were granted at $0.00 per share, and following this transaction, Weaving directly holds 3,558.44 Sempra shares. This insider activity indicates a neutral impact and sentiment according to the filing analysis.

American Water Works Company, Inc. director Michael Marberry received an equity award of 1,374 common stock units, which vested immediately upon grant and converted into shares. This compensation-related grant, at no cash cost, increased his direct holdings to 11,395 common shares. The transaction was not an open-market purchase but an acquisition of stock units with a grant price of $0.0000 per share.

Insulet Corporation's stock recently reached a 52-week low of $148.09, reflecting a significant decline of nearly 50% over the past year and a 44% year-to-date drop. Despite strong Q1 financial results with sales of $762 million, surpassing estimates, analysts have adjusted price targets downward due to concerns about guidance and valuation. InvestingPro analysis suggests the stock may be undervalued and maintains a "GREAT" financial health score.

Arcutis Biotherapeutics (ARQT) officer Patrick Burnett sold 222 shares of common stock at $21.05 per share. This sale was conducted to cover tax withholding obligations associated with the vesting of his Restricted Stock Units. After the transaction, Burnett directly owns 120,244 shares, indicating the sale was a compensation-related tax event and not a discretionary reduction in his investment.

Axsome Therapeutics Inc. stock reached an all-time high of $234.57, reflecting a 123.94% increase over the past year and a market capitalization of $12 billion. Despite a significant earnings miss in Q1 2026, with a net loss of $1.26 per share, investor optimism persists. The company's revenue surged 64% over the last twelve months to $708 million, maintaining a gross profit margin of 93%.

The SPDR S&P 500 ETF Trust (SPY) increased by 0.56% on May 13, driven by a strong performance in AI and semiconductor stocks, despite higher-than-expected inflation data. The ETF saw $4 billion in net inflows over five days and has a Strong Buy rating from analysts with an implied upside potential of 15.67%. Its top holdings with upside potential include Carvana and Loews, while Ciena and Intel are among those with the greatest downside potential.